You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

AstraZeneca’s Tezspire receives approval for asthma treatment

AstraZeneca’s (AZ) Tezspire has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP).